LivaNova PLC LIVN

LIVN Company Overview

LivaNova PLC is a global medical technology company focused on developing and commercializing devices and therapies for neurological and cardiovascular conditions. The company operates primarily in the medical devices and healthcare technology industries, with core activities centered on neuromodulation and cardiopulmonary solutions. Its principal revenue drivers include vagus nerve stimulation therapies for drug-resistant epilepsy and depression, as well as heart-lung machine systems and related consumables used in cardiac surgery procedures.

The company traces its origins to the 2015 merger of Italy-based Sorin S.p.A. and U.S.-based Cyberonics, Inc., creating a diversified medtech business with operations spanning Europe and North America. LivaNova has positioned itself around highly specialized therapeutic markets where long product development cycles, regulatory approvals, and physician relationships create barriers to entry. Its products are primarily sold to hospitals, surgical centers, and healthcare systems, with a significant customer base in the United States and Europe.